Emerging trends and hotspots in metabolic dysfunction-associated fatty liver disease (MAFLD) research from 2012 to 2021: A bibliometric analysis

BackgroundMetabolic dysfunction-associated fatty liver disease (MAFLD) has become the most common chronic liver disease. MAFLD is a major risk factor for end-stage liver disease including cirrhosis and primary liver cancer. The pathogenesis of MAFLD is complex and has not yet been clarified. To the...

Full description

Bibliographic Details
Main Authors: Yudi Liao, Liya Wang, Fang Liu, Yanyu Zhou, Xiaoqi Lin, Zijun Zhao, Saihong Xu, Dan Tang, Yingfu Jiao, Liqun Yang, Weifeng Yu, Po Gao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1078149/full
_version_ 1797944997029347328
author Yudi Liao
Yudi Liao
Liya Wang
Fang Liu
Fang Liu
Yanyu Zhou
Xiaoqi Lin
Zijun Zhao
Saihong Xu
Dan Tang
Yingfu Jiao
Liqun Yang
Weifeng Yu
Weifeng Yu
Po Gao
author_facet Yudi Liao
Yudi Liao
Liya Wang
Fang Liu
Fang Liu
Yanyu Zhou
Xiaoqi Lin
Zijun Zhao
Saihong Xu
Dan Tang
Yingfu Jiao
Liqun Yang
Weifeng Yu
Weifeng Yu
Po Gao
author_sort Yudi Liao
collection DOAJ
description BackgroundMetabolic dysfunction-associated fatty liver disease (MAFLD) has become the most common chronic liver disease. MAFLD is a major risk factor for end-stage liver disease including cirrhosis and primary liver cancer. The pathogenesis of MAFLD is complex and has not yet been clarified. To the best of our knowledge, few studies have conducted quantitative bibliometric analysis to evaluate published MAFLD research. In this study, we conducted a comprehensive analysis of MAFLD publications over the past decade to summarize the current research hotspots and predict future research directions in this field.MethodsArticles into MAFLD published from 2012 to 2021 were identified from the Science Citation Index-Expanded of Web of Science Core Collection. CiteSpace software, VOSviewer, the “bibliometrix” R package, and the Online Analysis Platform of Literature Metrology were used to analyze the current publication trends and hotspots.ResultsWe retrieved 13959 English articles about MAFLD published from 2012 to 2021. Primary sites of publication were dominated by the United States until 2014, when China became the source of most published MAFLD-related research papers. The United States was found to be the most engaged country in international cooperative efforts. Shanghai Jiao Tong University was the most productive institution. Loomba R was the most productive author with 123 articles. The co-cited keyword cluster tag showed ten main clusters: #0 liver fibrosis, #1 hemoglobin, #2 metabolic associated fatty liver disease, #3 egcg, #4 myocardial infarction, #5 heart disease, #6 pnpla3, #7 hepatocellular carcinoma, #8 noninvasive marker, and #9 children. Keyword burst analysis showed that gut microbiota was the highest-intensity research hotspot.ConclusionIn the past decade, the number of publications on MAFLD increased dramatically, especially in the last three years. Gut microbiota became an important research direction for etiological and therapeutic investigations into MAFLD. Insulin resistance was also a key factor in studying the development of MAFLD in recent years. Liver fibrosis was an important focus of disease development. This study provides systematic information, helps guide future research, and helps to identify mechanisms and new treatment methods for MAFLD.
first_indexed 2024-04-10T20:48:24Z
format Article
id doaj.art-bfb1bb1f235749d59676d3230451417f
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-10T20:48:24Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-bfb1bb1f235749d59676d3230451417f2023-01-24T05:17:30ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-01-011410.3389/fendo.2023.10781491078149Emerging trends and hotspots in metabolic dysfunction-associated fatty liver disease (MAFLD) research from 2012 to 2021: A bibliometric analysisYudi Liao0Yudi Liao1Liya Wang2Fang Liu3Fang Liu4Yanyu Zhou5Xiaoqi Lin6Zijun Zhao7Saihong Xu8Dan Tang9Yingfu Jiao10Liqun Yang11Weifeng Yu12Weifeng Yu13Po Gao14Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaNMPA Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Jiangsu Province Key Laboratory of Anesthesiology, Jiangsu Province Key Laboratory of Anesthesia and Analgesia, Xuzhou Medical University, Xuzhou, ChinaDepartment of Gynecologic Oncology, International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaNMPA Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Jiangsu Province Key Laboratory of Anesthesiology, Jiangsu Province Key Laboratory of Anesthesia and Analgesia, Xuzhou Medical University, Xuzhou, ChinaDepartment of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaNMPA Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Jiangsu Province Key Laboratory of Anesthesiology, Jiangsu Province Key Laboratory of Anesthesia and Analgesia, Xuzhou Medical University, Xuzhou, ChinaDepartment of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaBackgroundMetabolic dysfunction-associated fatty liver disease (MAFLD) has become the most common chronic liver disease. MAFLD is a major risk factor for end-stage liver disease including cirrhosis and primary liver cancer. The pathogenesis of MAFLD is complex and has not yet been clarified. To the best of our knowledge, few studies have conducted quantitative bibliometric analysis to evaluate published MAFLD research. In this study, we conducted a comprehensive analysis of MAFLD publications over the past decade to summarize the current research hotspots and predict future research directions in this field.MethodsArticles into MAFLD published from 2012 to 2021 were identified from the Science Citation Index-Expanded of Web of Science Core Collection. CiteSpace software, VOSviewer, the “bibliometrix” R package, and the Online Analysis Platform of Literature Metrology were used to analyze the current publication trends and hotspots.ResultsWe retrieved 13959 English articles about MAFLD published from 2012 to 2021. Primary sites of publication were dominated by the United States until 2014, when China became the source of most published MAFLD-related research papers. The United States was found to be the most engaged country in international cooperative efforts. Shanghai Jiao Tong University was the most productive institution. Loomba R was the most productive author with 123 articles. The co-cited keyword cluster tag showed ten main clusters: #0 liver fibrosis, #1 hemoglobin, #2 metabolic associated fatty liver disease, #3 egcg, #4 myocardial infarction, #5 heart disease, #6 pnpla3, #7 hepatocellular carcinoma, #8 noninvasive marker, and #9 children. Keyword burst analysis showed that gut microbiota was the highest-intensity research hotspot.ConclusionIn the past decade, the number of publications on MAFLD increased dramatically, especially in the last three years. Gut microbiota became an important research direction for etiological and therapeutic investigations into MAFLD. Insulin resistance was also a key factor in studying the development of MAFLD in recent years. Liver fibrosis was an important focus of disease development. This study provides systematic information, helps guide future research, and helps to identify mechanisms and new treatment methods for MAFLD.https://www.frontiersin.org/articles/10.3389/fendo.2023.1078149/fullMAFLDNAFLDbibliometric analysis (BA)hotspotsCiteSpace
spellingShingle Yudi Liao
Yudi Liao
Liya Wang
Fang Liu
Fang Liu
Yanyu Zhou
Xiaoqi Lin
Zijun Zhao
Saihong Xu
Dan Tang
Yingfu Jiao
Liqun Yang
Weifeng Yu
Weifeng Yu
Po Gao
Emerging trends and hotspots in metabolic dysfunction-associated fatty liver disease (MAFLD) research from 2012 to 2021: A bibliometric analysis
Frontiers in Endocrinology
MAFLD
NAFLD
bibliometric analysis (BA)
hotspots
CiteSpace
title Emerging trends and hotspots in metabolic dysfunction-associated fatty liver disease (MAFLD) research from 2012 to 2021: A bibliometric analysis
title_full Emerging trends and hotspots in metabolic dysfunction-associated fatty liver disease (MAFLD) research from 2012 to 2021: A bibliometric analysis
title_fullStr Emerging trends and hotspots in metabolic dysfunction-associated fatty liver disease (MAFLD) research from 2012 to 2021: A bibliometric analysis
title_full_unstemmed Emerging trends and hotspots in metabolic dysfunction-associated fatty liver disease (MAFLD) research from 2012 to 2021: A bibliometric analysis
title_short Emerging trends and hotspots in metabolic dysfunction-associated fatty liver disease (MAFLD) research from 2012 to 2021: A bibliometric analysis
title_sort emerging trends and hotspots in metabolic dysfunction associated fatty liver disease mafld research from 2012 to 2021 a bibliometric analysis
topic MAFLD
NAFLD
bibliometric analysis (BA)
hotspots
CiteSpace
url https://www.frontiersin.org/articles/10.3389/fendo.2023.1078149/full
work_keys_str_mv AT yudiliao emergingtrendsandhotspotsinmetabolicdysfunctionassociatedfattyliverdiseasemafldresearchfrom2012to2021abibliometricanalysis
AT yudiliao emergingtrendsandhotspotsinmetabolicdysfunctionassociatedfattyliverdiseasemafldresearchfrom2012to2021abibliometricanalysis
AT liyawang emergingtrendsandhotspotsinmetabolicdysfunctionassociatedfattyliverdiseasemafldresearchfrom2012to2021abibliometricanalysis
AT fangliu emergingtrendsandhotspotsinmetabolicdysfunctionassociatedfattyliverdiseasemafldresearchfrom2012to2021abibliometricanalysis
AT fangliu emergingtrendsandhotspotsinmetabolicdysfunctionassociatedfattyliverdiseasemafldresearchfrom2012to2021abibliometricanalysis
AT yanyuzhou emergingtrendsandhotspotsinmetabolicdysfunctionassociatedfattyliverdiseasemafldresearchfrom2012to2021abibliometricanalysis
AT xiaoqilin emergingtrendsandhotspotsinmetabolicdysfunctionassociatedfattyliverdiseasemafldresearchfrom2012to2021abibliometricanalysis
AT zijunzhao emergingtrendsandhotspotsinmetabolicdysfunctionassociatedfattyliverdiseasemafldresearchfrom2012to2021abibliometricanalysis
AT saihongxu emergingtrendsandhotspotsinmetabolicdysfunctionassociatedfattyliverdiseasemafldresearchfrom2012to2021abibliometricanalysis
AT dantang emergingtrendsandhotspotsinmetabolicdysfunctionassociatedfattyliverdiseasemafldresearchfrom2012to2021abibliometricanalysis
AT yingfujiao emergingtrendsandhotspotsinmetabolicdysfunctionassociatedfattyliverdiseasemafldresearchfrom2012to2021abibliometricanalysis
AT liqunyang emergingtrendsandhotspotsinmetabolicdysfunctionassociatedfattyliverdiseasemafldresearchfrom2012to2021abibliometricanalysis
AT weifengyu emergingtrendsandhotspotsinmetabolicdysfunctionassociatedfattyliverdiseasemafldresearchfrom2012to2021abibliometricanalysis
AT weifengyu emergingtrendsandhotspotsinmetabolicdysfunctionassociatedfattyliverdiseasemafldresearchfrom2012to2021abibliometricanalysis
AT pogao emergingtrendsandhotspotsinmetabolicdysfunctionassociatedfattyliverdiseasemafldresearchfrom2012to2021abibliometricanalysis